Alpha Tau Medical Ltd.
DRTS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001871321
In the last 90 days, Alpha Tau Medical Ltd. insiders filed 0 open-market purchases and 6 sales; 74 institutions reported holding it in 13F filings for Q2 2026, worth $100.1M in total; ARK Invest is the only superinvestor holding it.
Other share classesDRTSW
13F holders, Q1 2023
Institutional positions in Alpha Tau Medical Ltd. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +2 vs. Q4 2022
- Shares held
- 652.1K
- +108.1K (+19.9%) vs. Q4 2022
- Total value
- $1.87M
- +$173.5K (+10.2%) vs. Q4 2022
- New holders
- 4
- 3 more added
- Sold out
- 2
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DRTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 74 | $100.1M |
| Q1 2026 | 53 | $29.1M |
| Q4 2025 | 35 | $11.9M |
| Q3 2025 | 31 | $8.26M |
| Q2 2025 | 24 | $4.95M |
| Q1 2025 | 23 | $2.94M |
| Q4 2024 | 21 | $3.03M |
| Q3 2024 | 23 | $2.23M |
| Q2 2024 | 24 | $3.25M |
| Q1 2024 | 27 | $5.35M |
| Q4 2023 | 26 | $5.51M |
| Q3 2023 | 23 | $3.65M |
| Q2 2023 | 20 | $4.11M |
| Q1 2023 | 16 | $1.87M |
| Q4 2022 | 14 | $1.70M |
| Q3 2022 | 18 | $4.01M |
| Q2 2022 | 14 | $5.92M |
| Q1 2022 | 12 | $5.28M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Alpha Tau Medical Ltd.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 362,046 | $1.04M | 0.00% | 00.0% | Unchanged |
| ETF Managers Group, LLC | 66,326 | $190.4K | 0.01% | +66,326 | New |
| JPMorgan Chase & Co | 58,577 | $168.0K | 0.00% | −771−1.3% | Reduced |
| ProVise Management Group, LLC | 35,070 | $100.7K | 0.01% | +35,070 | New |
| Geode Capital Management, LLC | 26,606 | $76.4K | 0.00% | +6,364+31.4% | Added |
| Citigroup Inc | 24,104 | $69.2K | 0.00% | −22−0.1% | Reduced |
| Morgan Stanley | 18,603 | $53.4K | 0.00% | 00.0% | Unchanged |
| Circle Wealth Management, LLC | 14,500 | $41.6K | 0.01% | +14,500 | New |
| Wells Fargo & Company | 10,806 | $31.0K | 0.00% | 00.0% | Unchanged |
| Financial Guidance Group, Inc. | 10,260 | $29.4K | 0.02% | 00.0% | Unchanged |
| Opal Wealth Advisors, LLC | 10,000 | $28.7K | 0.02% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 6,050 | $17.4K | 0.00% | +6,050 | New |
| Tower View Investment Management & Research LLC | 5,566 | $16.0K | 0.01% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,500 | $4.00K | 0.00% | +500+50.0% | Added |
| UBS Group AG | 1,292 | $3.71K | 0.00% | −254−16.4% | Reduced |
| Bank of America Corp | 780 | $2.24K | 0.00% | +770+7,700.0% | Added |
| Summit Trail Advisors, LLC | 0 | $0 | 0.00% | −10,270−100.0% | Sold out |
| Phoenix Holdings Ltd. | 0 | $0 | 0.00% | −10,141−100.0% | Sold out |